Jianghong Zhong

Dr. Jianghong Zhong

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
MPMaria Peleli
Maria Peleli
CZChrista Zollbrecht
Christa Zollbrecht
MMMarcelo Montenegro
Marcelo Montenegro
MHMichael Hezel
Michael Hezel
JZJianghong Zhong
Jianghong Zhong
Mattias CarlstromMattias Carlstrom
Mattias Carlstrom

1 September 2018 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JZJianghong Zhong
Jianghong Zhong
LOLina M. Olsson
Lina M. Olsson
VUVilma Urbonaviciute
Vilma Urbonaviciute
MYMin Yang
Min Yang
LBLiselotte Bäckdahl
Liselotte Bäckdahl
Rikard HolmdahlRikard Holmdahl
Rikard Holmdahl

8 February 2011 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
JZJianghong Zhong
Jianghong Zhong
JTJie Tian
Jie Tian
XYXin Yang
Xin Yang
CQChenghu Qin
Chenghu Qin

8 August 2012 in Laser & Photonics Reviews
Verified
Journal Article
Closed access
PDF file
CQChenghu Qin
Chenghu Qin
JFJinchao Feng
Jinchao Feng
SZSHOUPING ZHU
SHOUPING ZHU
XMXibo Ma
Xibo Ma
JZJianghong Zhong
Jianghong Zhong
JTJie Tian
Jie Tian

13 July 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
JZJianghong Zhong
Jianghong Zhong
QLQijing Li
Qijing Li
HLHuqiao Luo
Huqiao Luo
Rikard HolmdahlRikard Holmdahl
Rikard Holmdahl
A single-nucleotide polymorphism of neutrophil cytosolic factor 1 (Ncf1), leading to an impaired generation of reactive oxygen species (ROS), is a causative genetic factor for autoimmune disease. To study a possible tumor protection effect by the Ncf1 mutation in a manner dependent on cell types, we used experimental mouse models of lung colonization assay by B16F10 melanoma cells. We observed fewer tumor foci in Ncf1 mutant mice, irrespective of αβT, γδT, B-cell deficiencies, or of a functional Ncf1 expression in CD68-positive monocytes/macrophages. The susceptibility to tumor colonization was restored by the human S100A8 (MRP8) promoter directing a functional Ncf1 expression to granulocytes. This effect was associated with an increase of both ROS and interleukin 1 beta (IL-1β) production from lung neutrophils. Moreover, neutrophil depletion by anti-Ly6G antibodies increased tumor colonization in wild type but failed in the Ncf1 mutant mice. In conclusion, tumor colonization is counteracted by ROS-activated and IL-1β-secreting tissue neutrophils.

4 May 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
JZJianghong Zhong
Jianghong Zhong
TSTatjana Scholz
Tatjana Scholz
AYAnthony C. Y. Yau
Anthony C. Y. Yau
SGSimon Guerard
Simon Guerard
UHUlrike Hüffmeier
Ulrike Hüffmeier
Rikard HolmdahlRikard Holmdahl
Rikard Holmdahl
Previous identification of the inducible nitric oxide synthase (NOS2) gene as a risk allele for psoriasis (Ps) and psoriatic arthritis (PsA) suggests a possible pathogenic role of nitric oxide (NO). Using a mouse model of mannan-induced Ps and PsA (MIP), where macrophages play a regulatory role by releasing reactive oxygen species (ROS), we found that NO was detectable before disease onset in mice, independent of a functional nicotinamide adenine dinucleotide phosphate oxidase 2 complex. MIP was suppressed by either deletion of Nos2 or inhibition of NO synthases with NG-nitro-l-arginine methyl ester, demonstrating that Nos2-derived NO is pathogenic. NOS2 expression was also up-regulated in lipopolysaccharide- and interferon-γ–stimulated monocyte subsets from patients with PsA compared to healthy controls. Nos2-dependent interleukin-1α (IL-1α) release from skin macrophages was essential for arthritis development by promoting IL-17 production of innate lymphoid cells. We conclude that Nos2-derived NO by tissue macrophages promotes MIP, in contrast to the protective effect by ROS.